Complement Inhibitors in Rare Diseases / 罕见病研究
JOURNAL OF RARE DISEASES
;
(4): 391-399, 2022.
Artículo
en Inglés
| WPRIM
| ID: wpr-1005034
ABSTRACT
The complement system is a self-protection mechanism of the human body. The abnormal activation of the complement system is involved in the occurrence and development of various diseases. The application of complement inhibitors in many rare diseases was a milestone in leading to the progress of such disease as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and others. Recently, the application of complement inhibitors has gradually expanded to other complement-related diseases. This review summarizes the literature on the current application of complement inhibitors in rare diseases and looks into the prospects of the application in the rare diseases.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Inglés
Revista:
JOURNAL OF RARE DISEASES
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS